Results
eNauka >
Results >
Transform-1: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, International Phase 3 Study of Navitoclax in Combination with Ruxolitinib Versus Ruxolitinib Plus Placebo in Patients with Untreated Myelofibrosis
| Title: | Transform-1: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, International Phase 3 Study of Navitoclax in Combination with Ruxolitinib Versus Ruxolitinib Plus Placebo in Patients with Untreated Myelofibrosis | Authors  : | Pemmaraju, Naveen; ...; Bogdanović, Andrija D.   ; ...; (broj koautora 24) |
Issue Date: | 2023 | Publication: | Blood (65th Annual Meeting of the American Society of Hematology (ASH), San Diego, CA, DEC 09-12, 2023) | ISSN: | 0006-4971 Blood Search Idenfier |
Publisher: | [New York] : Elsevier | Type: | Conference Paper | Collation: | vol. 142 br. Suppl 1 str. 620-620 | DOI: | 10.1182/blood-2023-173509 | WoS-ID: | 001159306702133 | URI: | https://enauka.gov.rs/handle/123456789/936675 | URL: | https://ashpublications.org/blood/article/142/Supplement%201/620/502738/Transform-1-A-Randomized-Double-Blind-Placebo | Metadata source: | (Preuzeto iz Nasi u WoS) | M-category: | Mp. category will be shown later |
Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.